Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more
Indoco Remedies Limited (INDOCO) - Total Liabilities
Latest total liabilities as of September 2025: ₹15.34 Billion INR
Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has total liabilities worth ₹15.34 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Indoco Remedies Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Indoco Remedies Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Indoco Remedies Limited Competitors by Total Liabilities
The table below lists competitors of Indoco Remedies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Emerging Display Technologies Corp
TW:3038
|
Taiwan | NT$1.30 Billion |
|
Eliem Therapeutics Inc
NASDAQ:ELYM
|
USA | $3.74 Million |
|
Forest Water Environmental Eng Co Ltd
TW:8473
|
Taiwan | NT$8.10 Billion |
|
Amulaire Thermal Technology
TW:2241
|
Taiwan | NT$719.57 Million |
|
Havilah Resources Ltd
AU:HAV
|
Australia | AU$1.77 Million |
|
Central Omega Resources Tbk PT
JK:DKFT
|
Indonesia | Rp1.84 Trillion |
|
Radisson Mining Resources Inc
OTCQB:RMRDF
|
USA | $9.51 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Indoco Remedies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.01 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Indoco Remedies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Indoco Remedies Limited (2004–2025)
The table below shows the annual total liabilities of Indoco Remedies Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹14.12 Billion | +36.48% |
| 2024-03-31 | ₹10.34 Billion | +64.18% |
| 2023-03-31 | ₹6.30 Billion | +8.34% |
| 2022-03-31 | ₹5.81 Billion | +6.48% |
| 2021-03-31 | ₹5.46 Billion | -7.76% |
| 2020-03-31 | ₹5.92 Billion | -0.90% |
| 2019-03-31 | ₹5.97 Billion | +6.44% |
| 2018-03-31 | ₹5.61 Billion | +2.91% |
| 2017-03-31 | ₹5.45 Billion | +43.74% |
| 2016-03-31 | ₹3.79 Billion | +16.11% |
| 2015-03-31 | ₹3.27 Billion | +20.13% |
| 2014-03-31 | ₹2.72 Billion | -1.19% |
| 2013-03-31 | ₹2.75 Billion | +1.36% |
| 2012-03-31 | ₹2.72 Billion | +26.69% |
| 2011-03-31 | ₹2.14 Billion | +27.19% |
| 2010-03-31 | ₹1.69 Billion | +22.78% |
| 2009-03-31 | ₹1.37 Billion | +14.15% |
| 2008-03-31 | ₹1.20 Billion | +5.50% |
| 2007-03-31 | ₹1.14 Billion | +1.49% |
| 2006-03-31 | ₹1.12 Billion | +2.47% |
| 2005-03-31 | ₹1.10 Billion | +75.30% |
| 2004-03-31 | ₹625.25 Million | -- |